So even in those with immunity, COVID19 is like a super-flu with extra abilities, which we used to worry about Boosters to prevent severe outcomes in the vulnerable, and reduce infection risk in everyone, are thus even more useful than typical flu shots statnews.com/2022/11/22/dat…

Yale researcher Akiko Iwasaki, PhD, says COVID-19 isn’t unique in its ability to leave behind post-viral illness after infection. Read the article in TIME: bit.ly/3Hpc0HJ Prof. Akiko Iwasaki @yaleIBIO

This thread is long so if you would like an unrolled one page web view that is easier to read or share, look at this tweet to find the link more quickly ( x.com/jeffgilchrist/… ). 2/

This study shows respirators lower risk of infection by 83%. Other masks are not as effective. cdc.gov/mmwr/volumes/7…

Played $400 stud/omaha hi lo last night. No clue what i was doing but fun table. Norman Chad check raised all in on the river which included one of his wedding rings. Good job I was bluffing 😁

On the tournament grind at the Horseshoe WSOP circuit 6 tournaments including venetian $1600, 8 entries, 4 cashes, 1 FT (7th). YTD 12 tournaments, 21 entries, 8 cashes, 3 FT. Still searching for that W!

UK visit: 28/450 at Nottingham 1100 wsopc ME. 25/305 at Blackpool 1250 ME. The brits play good! YTD 16 tournaments, 25 entries, 12 cashes, 3 FT.

$mdgl bought some jan $250 calls on this drop, will hold to see how this plays out.

Bryan William Jones unmc.edu/healthsecurity…

Kevin Bass N95 masks are highly effective in preventing COVID-19 transmission (Cai, 2023). However, it is important to note that they are not worn all the time. Many infections happen at home or in poorly ventilated indoor spaces where masks are not used (Elsebaie et al., 2023).

First human data for new XBB.1.5 booster vs the BA.2.86 variant: the neutralization antibody response looks very good, along with current main US circulating variants of EG.5.1 and FL.1.5.1 medrxiv.org/content/10.110… This adds to the 4 lab studies and is quite reassuring 👍

1. What concerns me the most, by far, about SARS-CoV-2, is that, in the absence of better vaccines and therapeutics, we are heading towards an inexorable reduction in global population health. Even if the virus maintains the same virulence, the data we now have on the average...

$CHRS reduction in spending by $15mm. Still at $300mm spend with $130mm in cash. Lots of moving parts commercially and cannot guide on cash flow positive. Surely better to get ahead of this with big spend reduction and manage from there. Might stabilize stock.

I’m gonna give 10 random people that repost this and follow me $25,000 for fun (the $250,000 my X video made) I’ll pick the winners in 72 hours

Cancers should no longer be classified only by their organ of origin - it's time for molecular characteristics to be used to classify tumors; for clinical practice as well as regulatory decision making. Commentary nature h/t Eric Topol

$mara take away gain from btc holdings, operationally lost 70MM this quarter and additional 40 million shares dilution, 100 million yoy. Very tough business if btc doesnt go significantly higher.

$rvph need to raise funds. 👀